| Symbol | DVHGF |
|---|---|
| Name | DEVONIAN HEALTH GROUP INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | G5V 4T1 Canada QC 360 rue des Entrepeneurs |
| Telephone | +1 4509792916 |
| Fax | — |
| — | |
| Website | http://groupedevonian.com/ |
| Incorporation | CA |
| Incorporated On | 2015 |
| Employees | — |
| Fiscal Year | 7/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | MNP LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: TSX Venture Exchange |
| CIK | — |
| Description | Devonian Health Group Inc. is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonians core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis. Additional info from OTC: |
No news found.